Search
Contact
Parkinson’s Disease Study: Potential New Option for Managing Parkinson’s Disease
Thursday, 29th January 2026
Monash House Research Centre is running a clinical trial for people living with Pakrinson’ disease, for an investigational therapy designed to deliver sustained relief from ‘off’ periods using a gentler, longer-acting pharmaceutical. It is administered via a small, easy-to-use wearable device avoiding the harsh side effects and skin reactions common with older treatments.
Who is Eligible to Participate?
You may be eligible to participate if you:
- A between 40-80 years old
- Have Parkinson’s disease
- Experience at least 2 hours of ‘off’ time during the day
- Are currently on a stable medication regime
- Are able to commit to an 8-day in-patient stay
Why Join the Study?
- Contribute to Progress: Help researchers develop better treatments that could reshape the future of Parkinson’s disease care.
- Reimbursement: You will receive financial reimbursement for your time, travel, and involvement in the study.
- Receive Expert Care: You’ll be closely monitored by specialists in Degenerative Diseases at our world-class research centre.
- Comfort & Convenience: Benefit from an up to 8-day stay in the private rooms of Monash House Private Hospital, where all meals are provided.
The reimbursement amount covers the full costs and commitment required for up to 8 days and follow-up. Details will be fully disclosed during the initial screening process.
Important Considerations
- This is a clinical trial and does not offer ongoing therapy after the study period is complete.
- Your usual Parkinson’s disease medications may be adjusted during the study to help researchers understand how the trial procedure works.
Trial Commitment & Monitoring
- Duration: The trial involves up to an 8-day (8 night) stay at our facility, followed by one or more outpatient follow-up visits.
- First Intake: Monash House is currently scheduling participants for the first intake, targeted for February – March, 2026.
- Delivery: The investigational medication is administered via a wearable device, which delivers the dose under the skin over about 10 minutes.
- Your Safety: A Safety Monitoring Committee will review all data. You will be continuously monitored for blood pressure, heart rhythm, skin reactions, mood, and any side effects. You can withdraw at any time.
- Suitability: All participants will undergo an initial assessment to check suitability; the trial may not be appropriate for everyone.